- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.10. | Notable Labs meldet Insolvenz an, Vorstand tritt zurück | 1 | Investing.com Deutsch | ||
| 15.10. | Notable Labs files for bankruptcy, board resigns | 1 | Investing.com | ||
| 15.10. | Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug | 4 | FierceBiotech | ||
| 15.10. | Notable Labs, Ltd. - 8-K, Current Report | - | SEC Filings | ||
| 10.10. | Notable Labs-Aktie erreicht 52-Wochen-Tief bei 0,38 US-Dollar | 1 | Investing.com Deutsch | ||
| 02.10. | Notable Labs stock touches 52-week low at $0.4 amid sharp annual decline | 3 | Investing.com | ||
| 02.10. | Notable Labs-Aktie erreicht 52-Wochen-Tief bei 0,4 US-Dollar | - | Investing.com Deutsch | ||
| 20.09. | Notable Labs-Aktie erreicht 52-Wochen-Tief bei 0,44 US-Dollar | 1 | Investing.com Deutsch | ||
| 20.09. | Notable Labs stock touches 52-week low at $0.44 amid market challenges | 1 | Investing.com | ||
| 20.09. | Notable Labs-Aktie unter Druck: Aussichten für Volasertib trüben sich ein - JMP | 1 | Investing.com Deutsch | ||
| 20.09. | Notable Labs stock under pressure as volasertib outlook dims - JMP | 1 | Investing.com | ||
| 19.09. | Notable Labs announces workforce reduction and strategic shift | 1 | Investing.com | ||
| 17.09. | Notable Labs appoints new interim CEO and restructuring officer | 1 | Investing.com | ||
| 16.09. | Notable Labs, Ltd. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.08. | Notable Labs to Present Data on September 4th at SOHO 2024 | 1 | GlobeNewswire (USA) | ||
| 26.08. | Notable Labs, Ltd. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 26.08. | Notable Labs, Ltd. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.08. | Notable Labs CEO steps down | 1 | Seeking Alpha | ||
| 26.08. | Notable Labs Announces CEO Transition | 100 | GlobeNewswire (Europe) | Thomas Bock, MD resigns as CEO; Joseph Wagner, PhD, CSO, appointed interim CEO Company affirms plan to initiate volasertib Phase 2 program in the coming months FOSTER CITY, Calif., Aug. 26, 2024 (GLOBE... ► Artikel lesen | |
| 14.08. | Notable Labs, Ltd. - 10-Q, Quarterly Report | 1 | SEC Filings |
Seite:
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| REDHILL BIOPHARMA | 8,360 | +1,95 % | RedHill Biopharma Ltd.: New Peer-Reviewed Publication of Opaganib Phase 2/3 Data Shows 62% Reduction in COVID-19 Mortality | Data, from a post hoc analysis of the randomized, placebo-controlled, double-blind phase 2/3 study of oral opaganib in COVID-19 pneumonia, showing a 62% reduction in mortality and a 21% improvement... ► Artikel lesen | |
| G1 THERAPEUTICS | 6,345 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.09.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 18.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.09.2024ISIN NameCA05461V2012 AXMIN... ► Artikel lesen | |
| WINDTREE THERAPEUTICS | 0,700 | -0,48 % | Windtree Therapeutics kündigt Optionsverkauf von Aktien im Wert von 27,24 Millionen US-Dollar an | ||
| NUCANA | 1,530 | +2,00 % | NuCana plc: NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States | EDINBURGH, United Kingdom, Sept. 25, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO) covering NUC-7738's... ► Artikel lesen | |
| CINGULATE | 3,835 | -5,07 % | Pre-market Movers: Cingulate, Greenland Technologies, Shimmick Corporation, Quantum BioPharma, CI&T | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.20 A.M. ET).In the Green Cingulate Inc. (CING) is up over 89% at $9.08.
Greenland... ► Artikel lesen | |
| GALMED | 6,500 | 0,00 % | Pre-market Movers: Portage Biotech, Veea, Intuitive Machines, Applied Therapeutics, Galmed Pharmaceuticals | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Portage Biotech Inc. (PRTG) is up over 179% at... ► Artikel lesen | |
| SCISPARC | 0,232 | -6,38 % | SciSparc Ltd: SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment | FDA confirms that SciSparc's study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc")... ► Artikel lesen | |
| ONCONETIX | 3,000 | +3,81 % | Onconetix, Inc. - S-1, General form for registration of securities | ||
| PORTAGE BIOTECH | 5,410 | -4,75 % | PORTAGE BIOTECH INC. - 6-K, Report of foreign issuer | ||
| BIOCARDIA | 2,390 | +2,58 % | BioCardia, Inc.: BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure | SUNNYVALE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases... ► Artikel lesen | |
| DERMATA THERAPEUTICS | 1,250 | -1,57 % | Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024 | SAN DIEGO, CA / ACCESSWIRE / October 8, 2024 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical... ► Artikel lesen | |
| ENSYSCE BIOSCIENCES | 0,622 | +8,00 % | Ensysce Biosciences, Inc.: Ensysce Biosciences Announces Leadership Team's Participation in the Annual Pain Therapeutics Summit | ~ Dr. Lynn Kirkpatrick to Present Latest Clinical Data for PF614 and PF614-MPAR ~~ Dr. William Schmidt to Deliver Opening Remarks as Summit Chair ~ SAN DIEGO, CA / ACCESSWIRE / October 8, 2024 / Ensysce... ► Artikel lesen | |
| TELESIS BIO | 3,150 | -21,05 % | Pre-market Movers: Telesis Bio, VS MEDIA, MDxHealth, Micron Technology, Pagaya Technologies | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.45 A.M. ET).In the Green Telesis Bio, Inc. (TBIO) is up... ► Artikel lesen | |
| DOGWOOD THERAPEUTICS | 4,280 | -1,61 % | Dogwood Therapeutics, Inc.: Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement | ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the "Company"), formerly Virios Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced today... ► Artikel lesen | |
| IMMUNEERING | 1,860 | 0,00 % | Pre-market Movers: Tenon Medical, Vision Marine Technologies, SMX, Singular Genomics Systems, Immuneering | SAN JOSE (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.00 A.M. ET).In the Green Tenon Medical, Inc. (TNON) is up over 350% at $19.80.
Vision... ► Artikel lesen |
NOTABLE LABS LTD gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell +0,04 % bei einem Aktienkurs von 0,248 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NOTABLE LABS LTD finden Sie auf Wallstreet Online.
